MedPath

Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease

Not Applicable
Completed
Conditions
Respiratory Insufficiency
Heart Failure
Lung Diseases, Interstitial
Palliative Medicine
Dyspnea
Pulmonary Disease, Chronic Obstructive
Lung Diseases
Palliative Care
Breathlessness
Neoplasms
Interventions
Behavioral: Cognitive and Behavioral intervention for the Management of Episodic Breathlessness
Registration Number
NCT04630743
Lead Sponsor
University of Cologne
Brief Summary

Episodic breathlessness is a common and distressing symptom in patients with advanced disease such as cancer, chronic obstructive pulmonary disease (COPD) and chronic heart failure. Since the short duration of the majority of breathless episodes limits the effectiveness of pharmacological interventions (e.g. opioids), non-pharmacological management strategies play a major role. As non-pharmacological strategies patients use, for example, cognitive and behavioural methods such as breathing or relaxation techniques.

The aim of the study is to test a brief cognitive and behavioural intervention for an improved management of episodic breathlessness. Initially, a Delphi procedure with international experts has been used to develop the brief intervention consisting of various non-pharmacological strategies to enhance the management of breathless episodes.

In the single-arm therapeutic exploratory trial (phase II), the feasibility and potential effects of the brief intervention, such as patient-reported breathlessness mastery, episodic breathlessness characteristics, quality of life, symptom burden, caregivers' burden, and breathlessness in general will be examined. The results of the study form the basis for planning and implementing a subsequent confirmatory randomized control trial (phase III).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • In- and outpatients of the participating centers with episodic breathlessness due to a life-limiting progressive disease
  • Recurrent breathlessness episodes despite optimal treatment of the underlying disease
  • Eastern Cooperative Oncology Group (ECOG) status 0-3
  • Estimated life-expectancy should be at least 8 weeks as judged by the treating physician
  • Ability to understand, read, and respond to German language
  • Informed consent
Exclusion Criteria
  • Episodic breathlessness due to reversible and treatable causes, such as acute pneumonia, pulmonary embolism, chronic hyperventilation syndrome, asthma or other reversible or unknown cause
  • Cognitive impairment
  • Severe current health impairments that do not allow participation after clinical evaluation by the treating physician

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cognitive and Behavioral InterventionCognitive and Behavioral intervention for the Management of Episodic BreathlessnessNon-pharmacological strategies for the Management of episodic breathlessness
Primary Outcome Measures
NameTimeMethod
Enrollment rate (Feasibility)week 6

Ratio of patients screened and patients that signed informed consent

Study completion rate (Feasibility)week 6

Ratio of patients who signed the informed consent and filled out the final assessment

Drop Outs (Feasibility)week 6

Withdrawal from the study at specific date (e.g. Intervention, refresher, Outcome at week 2/4/6)

Secondary Outcome Measures
NameTimeMethod
Satisfaction with the brief cognitive and behavioral intervention (Acceptability)week 6

closed-ended Questions

Patients' experience with the Intervention and study procedureweek 6

qualitative interview

Potential effects of the brief cognitive and behavioral Intervention on breathlessness masteryweek 2, 4 and 6

Mastery Domain of the Chronic Respiratory Questionnaire (the higher the score, the better the outcome)

Occurence of side-effects due to the brief cognitive and behavioral Intervention (Safety)week 6

closed-ended question (yes/no)

Occurence of adverse events due to the study procedure (Safety)week 6

closed-ended Question (yes/no)

Potential effects of the brief cognitive and behavioral Intervention on Depressionweek 2, 4 and 6

Hospital Anxiety and Depression Scale: the Depression Subscale (the higher the score, the worse the outcome)

Potential effects of the brief cognitive and behavioral Intervention on Anxietyweek 2, 4 and 6

Hospital Anxiety and Depression Scale: the Anxiety Subscale (the higher the score, the worse the outcome)

Occurence of adverse events due to the brief cognitive and behavioral Intervention (Safety)week 6

closed-ended Question (yes/no)

Potential effects of the brief cognitive and behavioral Intervention on Palliative Care needsweek 2, 4 and 6

Integrated Palliative Care Outcome Scale (the higher the score, the worse the outcome)

Potential effects of the brief cognitive and behavioral Intervention on Quality of Lifeweek 2, 4 and 6

Chronic Respiratory Questionnaire (the higher the score, the better the outcome)

Informal caregivers' burdens while caring for breathlessness patientsweek 2, 4 and 6

Zarid Burden Interview (the higher the score, the worse the Outcome)

Potential effects of the brief cognitive and behavioral Intervention on catastrophizing thoughts concerning dyspneaweek 2, 4 and 6

Dyspnea catastrophizing scale (the higher the score, the worse the outcome)

Informal caregivers' experience with Intervention and study procedureweek 6

qualitative interview

Trial Locations

Locations (1)

University Hospital of Cologne

🇩🇪

Cologne, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath